Market Place
Sourcing Support
Sanofi becomes Latest Pharma to Hold fire on UK R&D Investments
16 Sep 2025 //
FIERCE BIOTECH
Sanofi: Total Voting Rights and Shares Update - August 2025
12 Sep 2025 //
GLOBENEWSWIRE
Sanofi Triumphs at 2025 Fierce Pharma Marketing Awards
11 Sep 2025 //
FIERCE PHARMA
Sanofi`s SAR402663 Granted Fast Track Status for Neovascular AMD
11 Sep 2025 //
PRESS RELEASE
Tzield Approved in China: 1st Therapy for Stage 2 Type 1 Diabetes
11 Sep 2025 //
PRESS RELEASE
Sanofi Creates `Celebrity Mom Squad` for Beyfortus RSV Drive
10 Sep 2025 //
FIERCE PHARMA
Vyome Holdings Bolsters Team for Pivotal Trial Studies
09 Sep 2025 //
PHARMAWEB
Onco360® Chosen as National Pharmacy Partner for Wayrilz
08 Sep 2025 //
GLOBENEWSWIRE
Expert Discusses Future Research and Definitions in CIDP Care
08 Sep 2025 //
FIERCE PHARMA
New Data across Sanofi’s Immunology Pipeline reinforce leadership
05 Sep 2025 //
PRESS RELEASE
Thermo Fisher Scientific Buys NJ Site from Sanofi
02 Sep 2025 //
PRESS RELEASE
Genzyme`s Wayrilz Receives Approval in US
29 Aug 2025 //
FDA
Sanofi`s Wayrilz FDA Approved as First BTK Inhibitor for Immune
29 Aug 2025 //
PRESS RELEASE
Sanofi Joins Report Spotlighting Community Health Workers
27 Aug 2025 //
FIERCE PHARMA
Sanofi snags BioMarin Leader to Serve as CMO
26 Aug 2025 //
FIERCE BIOTECH
Sanofi discloses total voting rights, shares for July 2025
18 Aug 2025 //
GLOBENEWSWIRE
First T1D Treatment Licensed for Stage 3 Delay in Adults and Kids
15 Aug 2025 //
PHARMAWEB
Response’s Ex-Sanofi Asset Hits Goal in Post-GLP-1 Patients
15 Aug 2025 //
FIECE BIOTECH
Sanofi`s Rilzabrutinib Granted EU Orphan Designation
14 Aug 2025 //
PRESS RELEASE
Sanofi Completes the Acquisition of Vigil Neuroscience
06 Aug 2025 //
PRESS RELEASE
Sanofi India Reports Rs. 60.7 Cr Pat in Q2 2025
05 Aug 2025 //
INDPHARMAPOST
Sanofi pens $395M China pact for Arrowhead Metabolic med
02 Aug 2025 //
PRESS RELEASE
Sanofi`s Avapro Receives Approval in US
01 Aug 2025 //
FDA
Sanofi’s SAR446523 Gets US Orphan Drug Tag For Multiple Myeloma
31 Jul 2025 //
PRESS RELEASE
Q4 Sales Up 10.3%, EPS Beats FY24, Rebound Expected in 2025
31 Jul 2025 //
PRESS RELEASE
Sanofi’s Sarclisa Approved in EU for Multiple Myeloma
25 Jul 2025 //
PRESS RELEASE
Sanofi Supports Film About Women`s Experiences with Hemophilia
24 Jul 2025 //
FIERCE PHARMA
Kyowa, Amgen, Sanofi Support Women`s Health Info Update
23 Jul 2025 //
FIERCE PHARMA
Sanofi to Buy Respiratory Vaccine Biotech Vicebio for $1.6 B
23 Jul 2025 //
PRESS RELEASE
Beyfortus Cuts RSV disease Visits by 87% in US Study
22 Jul 2025 //
PR NEWSWIRE
Sanofi Completes Acquisition of Blueprint Medicines
19 Jul 2025 //
PRESS RELEASE
Sanofi Extends Blueprint Tender Offer Period
17 Jul 2025 //
GLOBENEWSWIRE
Sanofi’s SAR446597 Earns Fast Track Designation in the US
17 Jul 2025 //
PRESS RELEASE
Thermo Fisher Snaps up Sanofi Fill-Finish Plant in New Jersey
17 Jul 2025 //
FIERCE PHARMA
Emcure, Sanofi ink Deal for Oral Anti-diabetic Products in India
17 Jul 2025 //
PRESS RELEASE
Delaware Court Backs Zantac Drugmakers in Cancer Lawsuits
12 Jul 2025 //
REUTERS
Sanofi Updates Total Voting Rights and Shares - June 2025
09 Jul 2025 //
GLOBENEWSWIRE
Respiratory Royalty Rally Around Rural COPD Education Drive
09 Jul 2025 //
FIERCE PHARMA
Veteran Venture Capitalists Launch Autoimmune firm Vie Ventures
09 Jul 2025 //
FIERCE BIOTECH
Sanofi takes up option on Adagene biospecific, invests $25M
02 Jul 2025 //
GLOBENEWSWIRE
Riliprubart Wins Japan Orphan Drug Tag for CIDP Therapy
30 Jun 2025 //
PRESS RELEASE
Press release: Availability of the Q2 2025 Aide mémoire
30 Jun 2025 //
PRESS RELEASE
Riliprubart Earns Orphan Drug Status in Us for Organ Rejection
25 Jun 2025 //
GLOBENEWSWIRE
US CDC vaccine panel postpones vote on RSV therapies
25 Jun 2025 //
REUTERS
Kymera Therapeutics Announces Sanofi IRAK4 Collaboration Update
25 Jun 2025 //
PRESS RELEASE
Sarclisa Recommended for EU Approval by CHMP for Myeloma
24 Jun 2025 //
PRESS RELEASE
Sanofi Signs €545M Deal to Explore Formation’s JAK/SYK Inhibitor
24 Jun 2025 //
PR NEWSWIRE
Dupixent US Approval For Bullous Pemphigoid Treatment
21 Jun 2025 //
PRESS RELEASE
Abu Dhabi Health Dept. and Sanofi Partner for Global Vaccines
18 Jun 2025 //
PR NEWSWIRE
Sanofi Successfully Prices €1.5 Billion Bond Issue
17 Jun 2025 //
GLOBENEWSWIRE
Dupixent Beats Xolair in Ph4 Nasal Polyp Study at EAACI 2025
15 Jun 2025 //
PRESS RELEASE
EQT Life Sciences Co-Leads $135M Series B Financing for SpliceBio
11 Jun 2025 //
PR NEWSWIRE
Sanofi: Voting rights and shares info - May 2025
09 Jun 2025 //
GLOBENEWSWIRE
Sanofi Ships Beyfortus Early Ahead of 2025–2026 RSV Season
09 Jun 2025 //
PRESS RELEASE
Sanofi Launches 2025 Global Stock Purchase Plan
05 Jun 2025 //
PRESS RELEASE
ASCO: Sarclisa data support subcutaneous administration
03 Jun 2025 //
PRESS RELEASE
Rilzabrutinib Grants Orphan Designation for Sickle Cell Disease
03 Jun 2025 //
PRESS RELEASE
Sanofi to buy US biopharma group Blueprint for over $9 billion
03 Jun 2025 //
PRESS RELEASE
Recludix Names STAT6 Inhibitor Candidate Under Sanofi Deal
02 Jun 2025 //
GLOBENEWSWIRE
Sanofi Extends License for Nurix`s STAT6 program
02 Jun 2025 //
PRESS RELEASE
